BTG (BTG)

 

BTG Share PerformanceMore

52 week high739.5 12/07/16
52 week low528.4 31/01/17
52 week change -42.0 (-6.94%)
4 week volume15,116,483 26/01/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Total Voting Rights

RNS Number: 7604V BTG PLC 01 February 2017 1 February 2017 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 1 February 2017: 1. the Company's issued share capital consists of 385,099,960 Ordinaryshares of 10p each admitted to trading, and each with one...

Broker Forecast - Deutsche Bank issues a broker note on BTG PLC

Deutsche Bank today reaffirms its buy investment rating on BTG PLC (LON:BTG) and cut its price target to 775p (from 8...

Broker Forecast - Peel Hunt issues a broker note on BTG PLC

Peel Hunt today initiates coverage of BTG PLC (LON:BTG) with a hold investment rating and price target of 630p.

Broker Forecast - Jefferies International issues a broker note on BTG PLC

Jefferies International today reaffirms its buy investment rating on BTG PLC (LON:BTG) and cut its price target to 775p (...

Broker Forecast - Panmure Gordon issues a broker note on BTG PLC

Panmure Gordon today reaffirms its buy investment rating on BTG PLC (LON:BTG) and set its price target at 737p.

Broker Forecast - JP Morgan Cazenove issues a broker note on BTG PLC

JP Morgan Cazenove today reaffirms its neutral investment rating on BTG PLC (LON:BTG) and cut its price target to 790...

Total Voting Rights

RNS Number: 2215T BTG PLC 03 January 2017 3 January 2017 BTG plc - To tal Voting Rights and Share Capital In accordance with FCA's Disclosure and Transparency Rule 5.6.1, BTG plc (the "Company") notifies that as at 3 January 2017: 1. the Company's issued share capital consists of 385,095,473 Ordinaryshares of 10p each admitted to trading, and each with one vo...

BTG's PneumRx Coils included in new guidelines

BTG has announced the inclusion of treatment with PneumRx Coils in guidelines for the management of chronic obstruc...

Fundamental DataMore

P/E ratio35.665
EPS15.8
Dividend yield0 %

Equity Research (BTG)

edison investment research
BTG plc
08/04/2016
Growth across all three divisions of BTG’s Interventional Medicine (IM) franchise (oncology, vascular and pulmonology), coupled with currency tailwinds, helped push FY16 revenue towards the upper end...
edison investment research
BTG plc
30/11/2015
BTG’s interim results have driven upgrades to our financial forecasts with a small boost to revenues from one-off Zytiga backdated royalties. Our operating expenses are broadly unchanged, but...
edison investment research
BTG plc
30/10/2015
BTG’s close period update saw a revision to its FY16 revenue guidance, targeting sales in the lower half of £410-440m (at $1.61/£). This is based on slower-than-expected Varithena sales, despite a...

Latest discussion posts More

  • Re: Overlooked!

    I think that there is a belief that Pharma. are overcharging, not sure though what he can do about it or how that would affect Btg in particular. Time will tell, however at the ...
    16-Feb-2017
    rikid
  • Re: Overlooked!

    wont go up until uncertainty over trumps policy on drugs is clear if he comes out and says they are overcharging then watch out below. risk/reward is too risky at this ...
    16-Feb-2017
    shugg1e
  • collaboration/ Society of Interventional Oncology

    BTG and Society of Interventional Oncology to explore role of minimally invasive therapies in immuno-oncology 15 February 2017 London, UK: BTG plc (LSE: BTG), the global ...
    16-Feb-2017
    d gaser

Users' HoldingsMore

Users who hold BTG also hold..
LLOYDS GRP.30%
GLAXOSMITHKLINE23%
NATIONAL GRID23%
VODAFONE GRP.22%
PZ CUSSONS22%

Codes & Symbols

ISINGB0001001592
SymbolsBTG, LSE:BTG, BTG.L, BTG:LN, LON:BTG, XLON:BTG